-
Jeremy Meinen
Giorgio ReinerPaolo Galfetti
Mr. Galfetti has more than thirty years of management experience in the pharmaceutical sector including in the areas of business development and licensing, operational strategic management, clinical research and pharmaceutical discovery and development. He held management positions in our organization since 1995 and currently serves as the Company’s Chief Business Officer.
-
Paolo Galfetti
Jeremy MeinenGiorgio Reiner
Mr. Reiner has over 30 years of R&D experience. He is leading the development of Relief's pharmaceutical technologies and new products. Mr. Reiner holds a Master's degree in Pharmaceutical Chemistry and Technology from the University of Pharmacy in Milan, Italy.
-
Giorgio Reiner
Paolo GalfettiJeremy Meinen
Mr. Meinen serves as Chief Financial Officer and Treasurer. Prior to joining Relief in April 2020, Mr. Meinen provided financial consulting and controlling services to companies in various industries. He is a Swiss certified public accountant and former licensed audit expert.
-
Thomas Elzinga
Peter de SvastichRaghuram (Ram) Selvaraju, Ph.D, M.B.A.
Raghuram (Ram) Selvaraju, Ph.D., MBA, is a Managing Director and Senior Healthcare Analyst in the Equity Research Division of H.C. Wainwright & Co., a New York-based full-service investment bank heavily focused on the healthcare sector. He has nearly 20 years of experience on Wall Street and previously was a pharmaceutical researcher at Serono in Switzerland. He holds Ph.D. and M.S. degrees from the University of Geneva and an M.B.A. from Cornell University.
-
Raghuram (Ram) Selvaraju, Ph.D, M.B.A.
Gregory Van BeekPeter de Svastich
Mr. de Svastich is a Managing Director at GEM. Mr. de Svastich has deep expertise in the areas of commercial banking, investment banking and alternative investments.
-
Peter de Svastich
Thomas ElzingaGregory Van Beek
Mr. Van Beek is a Managing Director at GEM, focusing on special situation investments in both public capital markets and private opportunities. He has 25 years of experience in private equity, portfolio management, investment research and strategy.
-
Gregory Van Beek
Raghuram (Ram) Selvaraju, Ph.D, M.B.A.Thomas Elzinga
Mr. Elzinga is an Investment Associate at GEM. He is responsible for evaluating both public and private investment opportunities, as well as managing portfolio businesses.